Please note different locations each day.
Day 1 – Monday, Nov. 18, 2024
Eric P. Newman Education Center (EPNEC) Auditorium
320 S. Euclid Ave., first floor auditorium
Noon-1 p.m. Light Lunch
1-1:15 p.m. Opening Remarks
- Craig Buchman, MD, Washington University
- Linda Richards, PhD, Washington University
1:15-3:15 p.m. Session 1: Genetics / Gene Therapy
- 1:15-1:55 p.m.
Karen Avraham, PhD, Tel Aviv University
Gene Discovery to Gene Therapy: A Precision Medicine Approach - 1:55-2:35 p.m.
Zheng-Yi Chen, DPhil, Harvard Medical School
Gene Therapy for Genetic Hearing Loss: The Future Is Now - 2:35-3:15 p.m.
Michael McKenna, MD, Akouos
Gene Therapy for Inner Ear Conditions
3:15-3:45 p.m. Coffee Break
3:45-5:25 p.m. Session 2: CMV / Ototoxicity
- 3:45-4:25 p.m.
Albert Park, MD, University of Utah
Using a Murine Model to Elucidate the Host Immune Pathology of Congenital Cytomegalovirus (CMV) - 4:25-4:45 p.m.
Keiko Hirose, MD, Washington University
Congenital Cytomegalovirus and Antiviral Immunity in the Developing Mouse Cochlea - 4:45-5:05 p.m.
Jinkyung Kim, PhD, Washington University
In Vivo Tracking of Ototoxic Drug Transport Into the Cochlea - 5:05-5:25 p.m.
Mark Warchol, PhD, Washington University
Cytoskeletal Response to Ototoxic Injury in the Vestibular Maculae: Implications for Sensory Regeneration - 6-7 p.m. Special Lecture
Frank Lin, MD, PHD, Johns Hopkins University
Transforming Hearing Through Evidence, Policy and Awareness
Day 2 – Tuesday, Nov. 19, 2024
Jeffrey T. Fort Neuroscience Research Building Auditorium
4370 Duncan Ave., first floor
8:15-8:45 a.m. Light Breakfast
8:45 a.m.-11:35 a.m. Session 3: Hearing Loss
- 8:45-9:25 a.m.
John Oghalai, MD, University of Southern California
Imaging of the Human Ear Using Optical Coherence Tomography - 9:25-9:45 a.m.
Amit Walia, MD, Washington University
Electrocochleography-Guided Insights in Cochlear Implants: Mapping Place Coding and Intensity-Driven Tonotopic Changes - 9:45-10:05 a.m.
Lavinia Sheets, PhD, Washington University
From Riverside to Bedside: Zebrafish Insights Into Cisplatin-Induced Hearing Loss
10:05-10:35 a.m. Coffee Break
- 10:35-10:55 a.m.
Mark Rutherford, PhD, Washington University
Sex Dependent Effects of AMPA Receptor Composition on Synaptopathy and Cochlear Function - 10:55-11:35 a.m.
Tobias Moser, MD, University Medical Center Göttingen
Otoferlin — Related Auditory Synaptopathy
11:35 a.m.-12:35 p.m. Lunch
12:35-2:55 p.m. Session 4: Cortical Mechanisms
- 12:35-1:15 p.m.
Anne Takesian, PhD, Harvard Medical School
Diverse Cortical Layer 1 Circuits for Auditory Perception and Learning - 1:15-1:35 p.m.
Hysell Oviedo, PhD, Washington University
Asynchronous Development of the Mouse Auditory Cortex Is Driven by Hemispheric Identity and Sex - 1:35-2:15 p.m.
Maria Geffen, PhD, University of Pennsylvania
Cortical Circuits for Dynamic Auditory Perception - 2:15-2:55 p.m.
Shihab Shamma, PhD, University of Maryland
1) Washington University’s Pivotal Contributions to Auditory Neuroscience and Research
and
2) The Auditory Cortex as a Sensorimotor Fulcrum for Speech and Music Perception
2:55-3:25 p.m. Coffee Break
3:25-5:45 p.m. Session 5: Hearing Loss / Cognitive Impairment
- 3:25-4:05 p.m.
Frank Lin, MD, PhD, Johns Hopkins University
Hearing Intervention, Cognition, and Brain Health: Results From the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) Randomized Trial - 4:05-4:45 p.m.
Willa Brenowitz, PhD, MPH, Kaiser Permanente Center for Health Research
What Explains the Associations Between Hearing Loss and Dementia?: Evaluating Alternative Pathways With Observational Data - 4:45-5:05 p.m.
Kate McClannahan, AuD, PhD, Washington University
Self- and Informant-Reported Hearing Difficulties in Adults With Mild Dementia - 5:05-5:45 p.m.
Justin Golub, MD, Columbia University
When Should We Start Treating Age-Related Hearing Loss?
5:45-6 p.m. Closing Remarks
- Craig Buchman, MD, Washington University
- Linda Richards, PhD, Washington University